[Myoclonic encephalopathy caused by bismuth salts. Efficacy of treatment with dimercaprol].
Three patients with myoclonic encephalopathy caused by bismuth salts are reported, one with the severe and another with the mild form; dimercaprol was effective for the rapid improvement of the symptoms in both. In one of the patients in whom the clearance of bismuth was calculated it was found to be increased after dimercaprol therapy. We think that dimercaprol is an effective drug for the therapy of myoclonic encephalopathy caused by bismuth salts.
J A
JA
Molina
L
L
Calandre
F
F
Bermejo
F
F
Posadas
J D
JD
Fernández-Ortega
D000328:Adult; D000368:Aged; D000863:Antacids / Q000009:adverse effects*; D001729:Bismuth / Q000009:adverse effects*; D001927:Brain Diseases / Q000139:chemically induced* / Q000188:drug therapy; D004112:Dimercaprol / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D005707:Gallic Acid / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009207:Myoclonus / Q000139:chemically induced* / Q000188:drug therapy; D009942:Organometallic Compounds / Q000009:adverse effects*
D000863:Antacids; D009942:Organometallic Compounds; D004112:Dimercaprol; D005707:Gallic Acid; C010804:bismuth subnitrate; D001729:Bismuth; C002170:bismuth subgallate
Encefalopatía mioclónica por sales de bismuto. Eficacia del tratamiento con dimercaprol.